AzTrials
AzTrials

Below Elbow AmputationRFIDIBTNCT01967004

Enhancing Upper Limb Prostheses With Radio Frequency Identification

A study testing Morph in people with Below Elbow Amputation, run by Infinite Biomedical Technologies at 2 sites in United States.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The purpose of this study is to determine if Radio Frequency Identification (RFID) can lead to greater prosthesis function and control. Subjects are asked to perform specific tasks and actions using the traditional control method, as well as RFID control. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Below Elbow Amputation
What is being tested?
Morph
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
10 participants
Where
2 sitesUnited States
Study dates
Aug 2013to Jun 2014
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Age 18 or greater.
  • Below elbow amputation, unilateral or bilateral.
  • Chronic stable amputation: > 6 months from amputation.
  • Stable prosthesis prescription: > 3 months since last major prosthesis modification.
  • Cognitively intact, as determined by Mini-Mental Status Examination score > 24.
  • Able to provide informed consent and available to participate in study activities.
  • No severe residual limb motor/sensory impairment or pain likely to interfere with treatment.
  • Expected to be medically and psychiatrically stable for study duration.

Who cannot join

  • Patients with diseases which weaken and/or adversely affect the control of skeletal muscle.
  • Patients with poor skin integrity.

Trial locations and contacts

2 sites in 1 country.

United States2 sites
  • Johns Hopkins Eastern Campus

    Baltimore, Maryland, 21218-3637

  • Johns Hopkins Eastern Campus

    Baltimore, Maryland, 21218

Other trials in United States

About this study

Official title: Validation of a Control Method for Upper Limb Myoelectric Prostheses Using Radio Frequency Identification (RFID)

The purpose of this study is to determine if Radio Frequency Identification (RFID) can lead to greater prosthesis function and control. Subjects are asked to perform specific tasks and actions using the traditional control method, as well as RFID control.

Being tested
Morph

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • MorphDevice

    Also called Myoelectrically-Operated RFID Prosthetic Hand

    Morph is a small electric controller that is retrofit into existing myoelectric prostheses to equip them with wireless identification capabilities. Specifically, Morph allows the prosthesis to react to RFID tags in the environment.

Study groups in NCT01967004
Study groupRoleWhat they receive
Functional AssessmentExperimentalParticipant will be asked to perform a series of tasks involving their prosthesis. These tasks can involve switching grips as well as moving objects.
Receives: Device: Morph

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Time required to perform different functional tasks

    Each participant will perform functional tests on the first visit. These tests consist of moving objects from one location to another, and performing certain muscle contraction patterns when prompted. The participant will then take the prosthesis, installed with morph, home for 3 months at most, and then return to perform another set of timed trials.

    Measured: 12 weeks

Secondary outcomes (1)
  1. Questionnaires on prosthesis function and satisfaction

    The questionnaires offer the participant the opportunity to express their experience and satisfaction with their prosthesis, during different tasks and at home.

    Measured: 20 minutes per questionnaire, total of 3 different questionnaires administered twice each

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Oct 2013 (estimated)
  2. Study startAug 2013
  3. Primary completionApr 2014 (estimated)
  4. Study completionJun 2014 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
10 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01967004
Sponsor's protocol ID
RFID-IBT-3600
Acronym
RFIDIBT
Status last verified
Oct 2013
First submitted
26 Sep 2013
Last updated
5 Mar 2014
Results posted
No

Questions about this trial

What is this clinical trial studying?

A study testing Morph in people with Below Elbow Amputation, run by Infinite Biomedical Technologies at 2 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 5 Mar 2014. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Time required to perform different functional tasks (time frame: 12 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Mar 2014.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in